161 related articles for article (PubMed ID: 29174470)
1. Associations Between Prostate Volume and Oncologic Outcomes in Men Undergoing Focal Cryoablation of the Prostate.
Elshafei A; Tay KJ; Kara O; Malkoc E; Nyame Y; Arora H; Hatem A; Patel SA; Lugnani F; Polascik TJ; Jones JS
Clin Genitourin Cancer; 2018 Apr; 16(2):e477-e482. PubMed ID: 29174470
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population.
Mendez MH; Passoni NM; Pow-Sang J; Jones JS; Polascik TJ
J Endourol; 2015 Oct; 29(10):1193-8. PubMed ID: 26058496
[TBL] [Abstract][Full Text] [Related]
3. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
4. Primary full-gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD Registry.
Dhar N; Ward JF; Cher ML; Jones JS
BJU Int; 2011 Aug; 108(4):508-12. PubMed ID: 21722288
[TBL] [Abstract][Full Text] [Related]
5. Hemigland Cryoablation of Localized Low, Intermediate and High Risk Prostate Cancer: Oncologic and Functional Outcomes at 5 Years.
Oishi M; Gill IS; Tafuri A; Shakir A; Cacciamani GE; Iwata T; Iwata A; Ashrafi A; Park D; Cai J; Desai M; Ukimura O; Bahn DK; Abreu AL
J Urol; 2019 Dec; 202(6):1188-1198. PubMed ID: 31347953
[TBL] [Abstract][Full Text] [Related]
6. Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen.
Kovac E; ElShafei A; Tay KJ; Mendez M; Polascik TJ; Jones JS
J Endourol; 2016 Jun; 30(6):624-31. PubMed ID: 26915721
[TBL] [Abstract][Full Text] [Related]
7. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
[TBL] [Abstract][Full Text] [Related]
8. Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation.
Nyame YA; Elshafei A; Greene DJ; Arora HC; Given RW; Tay KJ; Polascik TJ; Ross AE; Mouraviev VB; Lugnani F; Jones JS
J Endourol; 2017 May; 31(5):497-501. PubMed ID: 28437170
[TBL] [Abstract][Full Text] [Related]
9. Primary Whole-gland Cryoablation for Prostate Cancer: Biochemical Failure and Clinical Recurrence at 5.6 Years of Follow-up.
Oishi M; Gill IS; Ashrafi AN; Lin-Brande M; Nassiri N; Shin T; Bove A; Cacciamani GE; Ukimura O; Bahn DK; Abreu ALC
Eur Urol; 2019 Feb; 75(2):208-214. PubMed ID: 30274702
[TBL] [Abstract][Full Text] [Related]
10. Salvage prostate cryoablation: initial results from the cryo on-line data registry.
Pisters LL; Rewcastle JC; Donnelly BJ; Lugnani FM; Katz AE; Jones JS
J Urol; 2008 Aug; 180(2):559-63; discussion 563-4. PubMed ID: 18554664
[TBL] [Abstract][Full Text] [Related]
11. Anterior gland focal cryoablation: proof-of-concept primary prostate cancer treatment in select men with localized anterior cancers detected by multi-parametric magnetic resonance imaging.
Sze C; Tsivian E; Tay KJ; Schulman AA; Davis LG; Gupta RT; Polascik TJ
BMC Urol; 2019 Dec; 19(1):127. PubMed ID: 31805908
[TBL] [Abstract][Full Text] [Related]
12. Does Any Racial Disparity Exist in Oncologic Outcomes After Primary Cryotherapy for Prostate Cancer? A Matched-pair Comparative Analysis of the Cryo On-Line Data Registry.
Aminsharifi A; Polascik TJ; Tsivian M; Schulman A; Tsivian E; Tay KJ; Elshafei A; Jones JS
Clin Genitourin Cancer; 2018 Oct; 16(5):e1073-e1076. PubMed ID: 30054221
[TBL] [Abstract][Full Text] [Related]
13. Predictors of prostate-specific antigen biochemical recurrence in patients undergoing primary whole-gland prostate cryoablation.
Liu YY; Chiang PH; Chuang YC; Lee WC; Cheng YT; Wang HJ
Ann Surg Oncol; 2015 May; 22(5):1612-7. PubMed ID: 25287436
[TBL] [Abstract][Full Text] [Related]
14. Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry.
Li YH; Elshafei A; Agarwal G; Ruckle H; Powsang J; Jones JS
Prostate; 2015 Jan; 75(1):1-7. PubMed ID: 25283814
[TBL] [Abstract][Full Text] [Related]
15. Focal cryosurgical ablation of the prostate: a single institute's perspective.
Hale Z; Miyake M; Palacios DA; Rosser CJ
BMC Urol; 2013 Jan; 13():2. PubMed ID: 23311921
[TBL] [Abstract][Full Text] [Related]
16. Focal Cryoablation of the Prostate: Primary Treatment in 163 Patients With Localized Prostate Cancer.
Khan A; Khan AU; Siref L; Feloney M
Cureus; 2023 Apr; 15(4):e37172. PubMed ID: 37153263
[TBL] [Abstract][Full Text] [Related]
17. Propensity Score-Matched Comparison of Partial to Whole-Gland Cryotherapy for Intermediate-Risk Prostate Cancer: An Analysis of the Cryo On-Line Data Registry Data.
Tay KJ; Polascik TJ; Elshafei A; Tsivian E; Jones JS
J Endourol; 2017 Jun; 31(6):564-571. PubMed ID: 28385075
[TBL] [Abstract][Full Text] [Related]
18. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome.
Ng CK; Moussa M; Downey DB; Chin JL
J Urol; 2007 Oct; 178(4 Pt 1):1253-7; discussion 1257. PubMed ID: 17698104
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Oncologic Outcomes of Salvage Cryoablation for Radio-Recurrent Prostate Cancer.
Siddiqui KM; Billia M; Al-Zahrani A; Williams A; Goodman C; Arifin A; Violette P; Bauman G; Chin JL
J Urol; 2016 Oct; 196(4):1105-11. PubMed ID: 27157372
[TBL] [Abstract][Full Text] [Related]
20. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer.
Bahn DK; Lee F; Badalament R; Kumar A; Greski J; Chernick M
Urology; 2002 Aug; 60(2 Suppl 1):3-11. PubMed ID: 12206842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
